The prevalence and year lived with disability of atopic dermatitis in China: Findings from the global burden of disease study 2019

Background: Atopic dermatitis (AD) is a chronic disease with growing prevalence and has become a global public health problem. However, little is known about the burden caused by AD in China. Objective: To access the prevalence and burden of AD in China. Methods: We estimated the prevalence and year...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Wen-lan Dong, MD, Jing An, MM, Miao Yu, MS, Peng Yin, MD, Ting-ling Xu, MM, Bo Liu, MD, Torsten Zuberbier, MD, PhD, Zuo-tao Zhao, MD, PhD, Mai-geng Zhou, MD, PhD
Formato:	article
Lenguaje:	EN
Publicado:	Elsevier 2021
Materias:	Atopic dermatitis Prevalence Years lived with disability Burden GBD 2019 Immunologic diseases. Allergy RC581-607
Acceso en línea:	https://doaj.org/article/8708dfaafd964f749ed18df8217fcafe
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:8708dfaafd964f749ed18df8217fcafe
record_format	dspace
spelling	oai:doaj.org-article:8708dfaafd964f749ed18df8217fcafe2021-11-10T04:23:00ZThe prevalence and year lived with disability of atopic dermatitis in China: Findings from the global burden of disease study 20191939-455110.1016/j.waojou.2021.100604https://doaj.org/article/8708dfaafd964f749ed18df8217fcafe2021-11-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S1939455121000983https://doaj.org/toc/1939-4551Background: Atopic dermatitis (AD) is a chronic disease with growing prevalence and has become a global public health problem. However, little is known about the burden caused by AD in China. Objective: To access the prevalence and burden of AD in China. Methods: We estimated the prevalence and year lived with disability (YLD) of AD in China, by different age and sex groups. We also compared the burden of AD in China with other countries in the Group of Twenty (G20). We analyzed the changes in the number of AD patients and their YLDs by cause decomposition from 1990 to 2019. Results: AD was the twenty-fourth leading cause of the burden of 369 diseases in China in 2019. From 1990 to 2019, the age-standardized prevalence and YLD rate of AD in China increased by 1.04% and 1.43% respectively, which were the second and the largest increase among the G20 and both higher than the global average (−4.29% and −4.14%). The number of patients with AD increased by 25.65%, of which 20.16% was due to population growth, 3.85% due to population aging, and 1.64% due to age-specific prevalence. Both the prevalence and YLD rate of AD were higher in 1 to 4 year-olds and 95+ years age group. Before the age of 10, the prevalence and YLD rate of AD in males were higher than those in females, while there was a marked sex shift at the ages of 10 to 14. Conclusion: AD is a serious public health problem in China. Substantial variations exist in burden due to AD between male and female, and in age groups. Considering these findings will be important for developing preventive strategies and treatments to reduce the burden of AD.Wen-lan Dong, MDJing An, MMMiao Yu, MSPeng Yin, MDTing-ling Xu, MMBo Liu, MDTorsten Zuberbier, MD, PhDZuo-tao Zhao, MD, PhDMai-geng Zhou, MD, PhDElsevierarticleAtopic dermatitisPrevalenceYears lived with disabilityBurdenGBD 2019Immunologic diseases. AllergyRC581-607ENWorld Allergy Organization Journal, Vol 14, Iss 11, Pp 100604- (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Atopic dermatitis Prevalence Years lived with disability Burden GBD 2019 Immunologic diseases. Allergy RC581-607
spellingShingle	Atopic dermatitis Prevalence Years lived with disability Burden GBD 2019 Immunologic diseases. Allergy RC581-607 Wen-lan Dong, MD Jing An, MM Miao Yu, MS Peng Yin, MD Ting-ling Xu, MM Bo Liu, MD Torsten Zuberbier, MD, PhD Zuo-tao Zhao, MD, PhD Mai-geng Zhou, MD, PhD The prevalence and year lived with disability of atopic dermatitis in China: Findings from the global burden of disease study 2019
description	Background: Atopic dermatitis (AD) is a chronic disease with growing prevalence and has become a global public health problem. However, little is known about the burden caused by AD in China. Objective: To access the prevalence and burden of AD in China. Methods: We estimated the prevalence and year lived with disability (YLD) of AD in China, by different age and sex groups. We also compared the burden of AD in China with other countries in the Group of Twenty (G20). We analyzed the changes in the number of AD patients and their YLDs by cause decomposition from 1990 to 2019. Results: AD was the twenty-fourth leading cause of the burden of 369 diseases in China in 2019. From 1990 to 2019, the age-standardized prevalence and YLD rate of AD in China increased by 1.04% and 1.43% respectively, which were the second and the largest increase among the G20 and both higher than the global average (−4.29% and −4.14%). The number of patients with AD increased by 25.65%, of which 20.16% was due to population growth, 3.85% due to population aging, and 1.64% due to age-specific prevalence. Both the prevalence and YLD rate of AD were higher in 1 to 4 year-olds and 95+ years age group. Before the age of 10, the prevalence and YLD rate of AD in males were higher than those in females, while there was a marked sex shift at the ages of 10 to 14. Conclusion: AD is a serious public health problem in China. Substantial variations exist in burden due to AD between male and female, and in age groups. Considering these findings will be important for developing preventive strategies and treatments to reduce the burden of AD.
format	article
author	Wen-lan Dong, MD Jing An, MM Miao Yu, MS Peng Yin, MD Ting-ling Xu, MM Bo Liu, MD Torsten Zuberbier, MD, PhD Zuo-tao Zhao, MD, PhD Mai-geng Zhou, MD, PhD
author_facet	Wen-lan Dong, MD Jing An, MM Miao Yu, MS Peng Yin, MD Ting-ling Xu, MM Bo Liu, MD Torsten Zuberbier, MD, PhD Zuo-tao Zhao, MD, PhD Mai-geng Zhou, MD, PhD
author_sort	Wen-lan Dong, MD
title	The prevalence and year lived with disability of atopic dermatitis in China: Findings from the global burden of disease study 2019
title_short	The prevalence and year lived with disability of atopic dermatitis in China: Findings from the global burden of disease study 2019
title_full	The prevalence and year lived with disability of atopic dermatitis in China: Findings from the global burden of disease study 2019
title_fullStr	The prevalence and year lived with disability of atopic dermatitis in China: Findings from the global burden of disease study 2019
title_full_unstemmed	The prevalence and year lived with disability of atopic dermatitis in China: Findings from the global burden of disease study 2019
title_sort	prevalence and year lived with disability of atopic dermatitis in china: findings from the global burden of disease study 2019
publisher	Elsevier
publishDate	2021
url	https://doaj.org/article/8708dfaafd964f749ed18df8217fcafe
work_keys_str_mv	AT wenlandongmd theprevalenceandyearlivedwithdisabilityofatopicdermatitisinchinafindingsfromtheglobalburdenofdiseasestudy2019 AT jinganmm theprevalenceandyearlivedwithdisabilityofatopicdermatitisinchinafindingsfromtheglobalburdenofdiseasestudy2019 AT miaoyums theprevalenceandyearlivedwithdisabilityofatopicdermatitisinchinafindingsfromtheglobalburdenofdiseasestudy2019 AT pengyinmd theprevalenceandyearlivedwithdisabilityofatopicdermatitisinchinafindingsfromtheglobalburdenofdiseasestudy2019 AT tinglingxumm theprevalenceandyearlivedwithdisabilityofatopicdermatitisinchinafindingsfromtheglobalburdenofdiseasestudy2019 AT boliumd theprevalenceandyearlivedwithdisabilityofatopicdermatitisinchinafindingsfromtheglobalburdenofdiseasestudy2019 AT torstenzuberbiermdphd theprevalenceandyearlivedwithdisabilityofatopicdermatitisinchinafindingsfromtheglobalburdenofdiseasestudy2019 AT zuotaozhaomdphd theprevalenceandyearlivedwithdisabilityofatopicdermatitisinchinafindingsfromtheglobalburdenofdiseasestudy2019 AT maigengzhoumdphd theprevalenceandyearlivedwithdisabilityofatopicdermatitisinchinafindingsfromtheglobalburdenofdiseasestudy2019 AT wenlandongmd prevalenceandyearlivedwithdisabilityofatopicdermatitisinchinafindingsfromtheglobalburdenofdiseasestudy2019 AT jinganmm prevalenceandyearlivedwithdisabilityofatopicdermatitisinchinafindingsfromtheglobalburdenofdiseasestudy2019 AT miaoyums prevalenceandyearlivedwithdisabilityofatopicdermatitisinchinafindingsfromtheglobalburdenofdiseasestudy2019 AT pengyinmd prevalenceandyearlivedwithdisabilityofatopicdermatitisinchinafindingsfromtheglobalburdenofdiseasestudy2019 AT tinglingxumm prevalenceandyearlivedwithdisabilityofatopicdermatitisinchinafindingsfromtheglobalburdenofdiseasestudy2019 AT boliumd prevalenceandyearlivedwithdisabilityofatopicdermatitisinchinafindingsfromtheglobalburdenofdiseasestudy2019 AT torstenzuberbiermdphd prevalenceandyearlivedwithdisabilityofatopicdermatitisinchinafindingsfromtheglobalburdenofdiseasestudy2019 AT zuotaozhaomdphd prevalenceandyearlivedwithdisabilityofatopicdermatitisinchinafindingsfromtheglobalburdenofdiseasestudy2019 AT maigengzhoumdphd prevalenceandyearlivedwithdisabilityofatopicdermatitisinchinafindingsfromtheglobalburdenofdiseasestudy2019
_version_	1718440670753980416

The prevalence and year lived with disability of atopic dermatitis in China: Findings from the global burden of disease study 2019

Ejemplares similares